Stoke Therapeutics Inc (STOK)

03:12 AM

JPMorgan Chase & Co. Boosts Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

03:12 AM

May 03, 2025

Stoke Therapeutics (STOK) Expected to Announce Quarterly Earnings on Monday - Defense World

May 03, 2025

May 01, 2025

Technical analysis of Stoke Therapeutics Inc (STOK) stock chart patterns - uspostnews.com

May 01, 2025

May 01, 2025

Biogen tops estimates on rare disease strength, cuts full-year guidance - The Pharma Letter

May 01, 2025

May 01, 2025

Legal & General Group Plc Decreases Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

May 01, 2025

Apr 29, 2025

Market Momentum Report: Stoke Therapeutics Inc (STOK)’s Negative Close at 9.47 - DWinneX

Apr 29, 2025

Apr 29, 2025

Renaissance Technologies LLC Invests $1.42 Million in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 29, 2025

Apr 28, 2025

Stoke Therapeutics, Inc. (STOK) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance

Apr 28, 2025

Apr 24, 2025

Market Highlights: Stoke Therapeutics Inc (STOK) Ends on a High Note at 9.52 - DWinneX

Apr 24, 2025

Apr 24, 2025

Stoke Therapeutics Inc (STOK) deserves deeper analysis - uspostnews.com

Apr 24, 2025

Apr 24, 2025

Geode Capital Management LLC Purchases 6,264 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 24, 2025

Apr 23, 2025

Stoke Therapeutics (STOK) Soars 12.0%: Is Further Upside Left in the Stock? - MSN

Apr 23, 2025

Apr 22, 2025

Stoke Therapeutics (STOK) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Apr 22, 2025

Apr 21, 2025

Stoke Therapeutics Inc (STOK) rating initates by Chardan Capital Markets - knoxdaily.com

Apr 21, 2025

Apr 20, 2025

(STOK) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Apr 20, 2025

Apr 17, 2025

Leerink Partnrs Issues Optimistic Estimate for STOK Earnings - Defense World

Apr 17, 2025

Apr 16, 2025

Analysts Are More Bearish On Stoke Therapeutics, Inc. (NASDAQ:STOK) Than They Used To Be - simplywall.st

Apr 16, 2025

Apr 16, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Average Rating of “Buy” by Analysts - Defense World

Apr 16, 2025

Apr 15, 2025

Vanguard Group Inc. Sells 28,049 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 15, 2025

Apr 14, 2025

Wellington Management Group LLP Has $1.49 Million Stock Holdings in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 14, 2025

Apr 12, 2025

KLP Kapitalforvaltning AS Makes New Investment in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 12, 2025

Apr 11, 2025

Needham & Company LLC Reiterates Buy Rating for Stoke Therapeutics (NASDAQ:STOK) - Defense World

Apr 11, 2025

Apr 09, 2025

Needham Keeps Their Buy Rating on Stoke Therapeutics (STOK) - The Globe and Mail

Apr 09, 2025

Apr 05, 2025

Stoke Therapeutics, Inc.'s (NASDAQ:STOK) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio - simplywall.st

Apr 05, 2025

Apr 03, 2025

Stoke Therapeutics stock hits 52-week low at $6.09 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Stoke Therapeutics stock hits 52-week low at $6.09 amid market challenges - Investing.com India

Apr 03, 2025

Apr 03, 2025

Teacher Retirement System of Texas Purchases Shares of 10,219 Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Apr 03, 2025

Apr 01, 2025

Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference - Business Wire

Apr 01, 2025

Apr 01, 2025

Revolutionary RNA Treatment for Rare Disease: Stoke CEO to Reveal Latest Progress - Stock Titan

Apr 01, 2025

Mar 31, 2025

Analysts Love These 2 Growth Stocks That Have Over 200% Upside Potential - TradingView

Mar 31, 2025

Mar 30, 2025

Swiss National Bank Acquires 11,400 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Mar 30, 2025

Mar 28, 2025

FY2025 Earnings Forecast for STOK Issued By Chardan Capital - Defense World

Mar 28, 2025

Mar 27, 2025

Charles Schwab Investment Management Inc. Grows Stock Position in Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Mar 27, 2025

Mar 26, 2025

Stoke Therapeutics stock hits 52-week low at $7.20 amid market challenges By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Stoke Therapeutics stock hits 52-week low at $7.20 amid market challenges - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

Dravet Syndrome Market Expected to Experience Major Growth - openPR.com

Mar 26, 2025

Mar 25, 2025

Bank of New York Mellon Corp Acquires 1,330 Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK) - Defense World

Mar 25, 2025

Mar 25, 2025

(STOK) Technical Data - news.stocktradersdaily.com

Mar 25, 2025

Mar 24, 2025

Cantor Fitzgerald Issues Positive Forecast for STOK Earnings - Defense World

Mar 24, 2025

Mar 23, 2025

Wedbush Equities Analysts Raise Earnings Estimates for STOK - Armenian Reporter

Mar 23, 2025

Mar 22, 2025

Earnings Beat: Stoke Therapeutics, Inc. (NASDAQ:STOK) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo

Mar 22, 2025

Mar 22, 2025

Stoke Therapeutics, Inc. (NASDAQ:STOK) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Mar 22, 2025

Mar 22, 2025

Brokers Offer Predictions for STOK Q3 Earnings - Defense World

Mar 22, 2025

Mar 22, 2025

What is Leerink Partnrs’ Forecast for STOK Q1 Earnings? - Defense World

Mar 22, 2025

Mar 22, 2025

Q1 EPS Estimates for Stoke Therapeutics Increased by Wedbush - Defense World

Mar 22, 2025

Mar 21, 2025

Stoke Therapeutics general counsel sells shares totaling $35,731 By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Stoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Chardan Capital - Defense World

Mar 21, 2025

Mar 21, 2025

Analysts Issue Forecasts for STOK Q1 Earnings - Defense World

Mar 21, 2025